Biosig technologies supplements clarification on recent schedule 14a filing. closing of merger with streamex exchange corporation not affected

Proposal no. 1 (the acquisition proposal) to be adjourned pending final nasdaq approval; company operations, financings and closing of the merger transaction remain not impacted proposal no. 1 (the acquisition proposal) to be adjourned pending final nasdaq approval; company operations, financings and closing of the merger transaction remain not impacted
BSGM Ratings Summary
BSGM Quant Ranking